- Home
- LSAK vs RCKT Comparison
LSAK vs RCKT Comparison
Compare LSAK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- RCKT
- Stock Information
- Founded
- LSAK 1997
- RCKT 1999
- Country
- LSAK South Africa
- RCKT United States
- Employees
- LSAK N/A
- RCKT N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- RCKT Health Care
- Exchange
- LSAK Nasdaq
- RCKT Nasdaq
- Market Cap
- LSAK 384.3M
- RCKT 328.6M
- IPO Year
- LSAK N/A
- RCKT N/A
- Fundamental
- Price
- LSAK $4.32
- RCKT $3.85
- Analyst Decision
- LSAK
- RCKT Buy
- Analyst Count
- LSAK 0
- RCKT 13
- Target Price
- LSAK N/A
- RCKT $12.88
- AVG Volume (30 Days)
- LSAK 32.8K
- RCKT 3.1M
- Earning Date
- LSAK 11-05-2025
- RCKT 11-03-2025
- Dividend Yield
- LSAK N/A
- RCKT N/A
- EPS Growth
- LSAK N/A
- RCKT N/A
- EPS
- LSAK N/A
- RCKT N/A
- Revenue
- LSAK $659,702,000.00
- RCKT N/A
- Revenue This Year
- LSAK N/A
- RCKT N/A
- Revenue Next Year
- LSAK N/A
- RCKT $3,582.16
- P/E Ratio
- LSAK N/A
- RCKT N/A
- Revenue Growth
- LSAK 16.92
- RCKT N/A
- 52 Week Low
- LSAK $3.39
- RCKT $2.19
- 52 Week High
- LSAK $5.60
- RCKT $18.17
- Technical
- Relative Strength Index (RSI)
- LSAK 52.69
- RCKT 55.13
- Support Level
- LSAK $4.25
- RCKT $3.67
- Resistance Level
- LSAK $4.48
- RCKT $4.06
- Average True Range (ATR)
- LSAK 0.16
- RCKT 0.26
- MACD
- LSAK 0.04
- RCKT -0.00
- Stochastic Oscillator
- LSAK 71.93
- RCKT 39.57
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.